Senseonics VP of Product Development Hari Sree explains the tech behind the Eversense 365-day CGM and what's next in the ...
BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for ...
I’ve contributed to PCMag since 2019, covering all kinds of consumer electronics. As a self-identifying early adopter of technology, I’ve stumbled through the changing devices over the years and ...
In December, online rumors hinted at the fact that Dexcom may be planning to sunset its G6 CGM sensor model. The company has now started to notify patients of the discontinuation plan. The company ...
DexCom has been outperforming its peers since our last coverage in December. I expect further progress this year, as the company's long-suffering gross margin profile is set to reverse course over the ...
Dexcom is already working on its G8 sensor for continuous glucose monitoring (CGM). But before you get too excited, the product is still a couple of years out, CEO Jake Leach told MD+DI during the J.P ...
Aqara has announced the Spatial Multi-Sensor FP400, a new presence sensor that it says is precise enough to suss out whether you’re sitting, standing, or lying down. The FP400 builds on several past ...
When Dan Heller received his first batch of Dexcom’s latest continuous glucose monitors in early 2023, he decided to run a small experiment: He wore the new biosensor and the previous generation at ...
Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
DexCom (DXCM) stock ought to be included on your watchlist. Here is why – it is presently trading within the support range ($55.31 – $61.13), levels from which it has bounced significantly in the past ...